Health and Healthcare
5865 Articles
The December 15 short interest data have been compared with the previous report, and short interest was down in most…
The cities where life expectancies are the shortest tend to report lower household incomes and more unhealthy behaviors than cities…
The SEC has announced that Teva Pharmaceutical Industries has agreed to pay over $519 million to settle charges that it…
Drugmakers' stocks can get clobbered by regulatory investigations. That's what happened to this year's least successful company: Endo International, which…
These 10 cities had the longest life expectancies in the entire United States. They tend to have certain characteristics common.
Shares of Amphastar Pharmaceuticals fell on Tuesday after the company announced that a subsidiary had received a Complete Response Letter…
Although the week between Christmas and New Year’s is not a heavily traded one, one company is making a case…
Seattle Genetics shares were down double-digits after the company announced that the FDA has placed holds on several early-stage clinical…
Visterra has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding…
Shares of Merrimack Pharmaceuticals dropped on Wednesday after the company reported that it would stop a mid-stage cancer study.
Inovio Pharmaceuticals shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial.
Akebia Therapeutics shares saw a handy gain on Tuesday after the company reported a new collaboration with Otsuka Pharmaceutical.
Conatus Pharmaceuticals saw its shares more than double early on Tuesday after the company reported an exclusive collaboration and license…
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares hit a new 52-week high after the company reported a key…
Our top personal finance-related articles today. Your wallet will thank you later.